Logo
Kevin Eisenfrats Headshot
Report a problem with this profile
[email protected]

Kevin Eisenfrats      

Forbes 30 Under 30 in Healthcare; Cofounder, Contraline

Kevin Eisenfrats is the Cofounder and CEO of Contraline, Inc., a medical device company working to develop a non-hormonal and reversible male contraceptive. Contraline has raised $3.1 million to develop the contraceptive and its target approval year is 2021. Eisenfrats was recognized as a Forbes 30 Under 30 honoree in healthcare for his work with Contraline.

He is a graduate of the University of Virginia.

News

30 Under 30 2018: Healthcare
Kevin Eisenfrats, 24. Cofounder, Contraline. more. Ivonna Dumanyan, 23; Gabrielle Levac, 26. Cofounders, Fathom AI. more. Trit Garg, 28. Resident Physician ...
Kevin Eisenfrats, 24 - 2018 30 Under 30: Healthcare
Kevin Eisenfrats' Contraline has raised $3.1 million to develop a non-hormonal procedure that uses hydrogel to block sperm. It targets approval in 2021.

Related Speakers View all

More like Kevin